首页> 外文OA文献 >Purification of CD4+ T Cells for Adoptive Immunotherapy after Allogeneic Hematopoietic Stem Cell Transplantation

【2h】

Purification of CD4+ T Cells for Adoptive Immunotherapy after Allogeneic Hematopoietic Stem Cell Transplantation

机译：同种异体造血干细胞移植后用于过继免疫治疗的CD4 + T细胞的纯化

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Klyuchnikov Evgeny; Sputtek Andreas; Slesarchuk Olga; Lioznov Michael; Stübig Thomas; Bacher Ulrike; Amtsfeld Gitta; Merle Edeltraut; Reckhaus Marie-Luise; Fehse Boris; Wolschke Christine; Adjallé Raissa; Ayuk Francis; Zander Axel; Kröger Nicolaus;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Purification of CD4+ T cells for adoptive immunotherapy after allogeneic hematopoietic stem cell transplantation. [J] . Klyuchnikov E, Sputtek A, Slesarchuk O, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2011,第3期

机译：异体造血干细胞移植后CD4 + T细胞的纯化，用于过继免疫治疗。
2. Addition of varicella zoster virus-specific T cells to cytomegalovirus, Epstein-Barr virus and adenovirus tri-specific T cells as adoptive immunotherapy in patients undergoing allogeneic hematopoietic stem cell transplantation [J] . Ma Chun K. K., Blyth Emily, Clancy Leighton, Cytotherapy . 2015,第10期

机译：将水痘带状疱疹病毒特异性T细胞添加到巨细胞病毒，爱泼斯坦-巴尔病毒和腺病毒三特异性T细胞中，作为异基因造血干细胞移植患者的过继免疫疗法
3. Rituximab-based treatments followed by adoptive cellular immunotherapy for biopsy-proven EBV-associated post-transplant lymphoproliferative disease in recipients of allogeneic hematopoietic stem cell transplantation [J] . Jiang Xinmiao, Xu Lanping, Zhang Yu, Oncoimmunology. . 2016,第5期

机译：基于Rituximab的治疗，然后是通过对组织造血干细胞移植接受者进行活组织检查证明的EBV相关的移植后移植后淋巴抑制性疾病的养殖疗法
4. THE EFFECT OF INHIBITORY KILLER-CELL IG-LIKE RECEPTOR (IKIR) MATCHING IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT) [C] . David Senitzer, Joel Y. Sun, Arisa Oki, Clinical Histocompatibility Workshop. . 2009

机译：同种异体造血细胞移植（HCT）中抑制杀伤细胞IG样受体（IKIR）匹配的影响
5. Donor selection for patients undergoing allogeneic hematopoietic stem cell transplantation: Assessment of the priorities of Canadian hematopoietic stem cell transplant physicians. [D] . Tay, Jason. 2009

机译：接受同种异体造血干细胞移植的患者的供体选择：加拿大造血干细胞移植医生的优先事项评估。
6. Rituximab-based treatments followed by adoptive cellular immunotherapy for biopsy-proven EBV-associated post-transplant lymphoproliferative disease in recipients of allogeneic hematopoietic stem cell transplantation [O] . Xinmiao Jiang, Lanping Xu, Yu Zhang, 2016

机译：在接受异基因造血干细胞移植的患者中以利妥昔单抗为基础的治疗然后采用过继细胞免疫疗法针对活检证实的EBV相关的移植后淋巴增生性疾病
7. Rituximab-based treatments followed by adoptive cellular immunotherapy for biopsy-proven EBV-associated post-transplant lymphoproliferative disease in recipients of allogeneic hematopoietic stem cell transplantation [O] . Xinmiao Jiang, Lanping Xu, Yu Zhang, 2016

机译：基于Rituximab的治疗，然后是通过对同种分电质造血干细胞移植受者进行活组织检查证明EBV相关的移植后移植后淋巴抑制性疾病的养殖细胞免疫疗法
8. Adoptive Immunotherapy Combined with Hematopoietic Cell Transplantation as a Therapeutic Treatment of Prostate Cancer [R] . Graves, S. S., Storb, R., Stone, B., 2009

机译：过继免疫治疗联合造血细胞移植治疗前列腺癌

Purification of CD4+ T Cells for Adoptive Immunotherapy after Allogeneic Hematopoietic Stem Cell Transplantation

著录项

引文网络

相似文献

相关主题

期刊订阅